Meniere's disease might be an autoimmune condition?

Autoimmunity Reviews

Volumn 11, Issue 10, 2012, Pages 731-738

  Greco, A ^a   Gallo, A ^a   Fusconi, M ^a   Marinelli, C ^a   Macri, G F ^a   De Vincentiis, M ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

Aetiopathogenesis; Histopathology; Meniere's disease; Therapy

Indexed keywords

ACICLOVIR; ANTICOAGULANT AGENT; ANTIGEN; AURALGAN; ETANERCEPT; GANCICLOVIR; GLUCOCORTICOID; STEROID; VALACICLOVIR; VIRUS VECTOR; WARFARIN;

ANTIINFLAMMATORY ACTIVITY; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; CELL REGENERATION; DRUG BIOAVAILABILITY; EAR INJURY; GASTROINTESTINAL SYMPTOM; GENE THERAPY; GENE TRANSFER; GENETICS; HEADACHE; HERPES SIMPLEX; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL PARAMETERS; INNER EAR; MENIERE DISEASE; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PERCEPTION DEAFNESS; RASH; REVIEW; SURGICAL TECHNIQUE; THROMBOEMBOLISM; TINNITUS; TREATMENT RESPONSE; TREMOR; VERTIGO; VIRUS INFECTION;

ANIMALS; AUTOIMMUNE DISEASES; EAR, INNER; HUMANS; MENIERE DISEASE;

EID: 84864393212     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.01.004     Document Type: Review

References (93)

1. Ménière P. Maladies de l'oreille interne offrant des symptoms de la congestion cerebral apoplectiforme. Gaz Med de Paris 1961, 16:88.
2. Knapp H. A clinical analysis of the inflammatory affectation of the inner ear. Arch Ophthalmol Otolaryngol 1871, 4:204-283.
3. Portmann G. Vertigo: surgical treatment by opening of the saccus endolymphaticus. Arch Otolaryngol 1927, 6:309.
4. Guild S. The circulation of the endolymph. Am J Anat 1927, 39:57.
5. Dandy W.E. Meniere's disease: its diagnosis and method of treatment. Arch Surg 1928, 16:1127-1152.
6. Altmann F., Fowler E. Histological findings in Meniere's symptom complex. Ann Otol Rhinol 1943, 52:52-80.
7. Kimura R.S. Experimental blockage of the endolymphatic sac and duct and its effect on the inner ear of the guinea pig. Ann Otol Rhinol Laryngol 1967, 76:4664-4687.
8. Stahle J., Stahle C., Arenberg I.K. Incidence of Meniere's disease. Arch Otolaryngol 1978, 104:99-102.
9. Nakae K., Komatuzaki K. Epidemiological study of Meniere's disease. Pract Otol (Kyoto) 1984, 69:1783-1788.
10. Tokumasu K., Tashiro N., Goto K. Incidence and prevalence of Meniere's disease in Asgamihara City, Kanagawa-ken. Pract Otol (Kyoto) 1983, 1(Suppl. 3):1165-1175.
11. Kotimaki J., Sorri M., Aantaa E., Nuutinen J. Prevalence of Meniere's disease in Finland. Laryngoscope 1999, 109:748-753.
12. Paparella M.M., da Costa S.S., Fox R., Yoo T.H. Meniere's disease and other labyrinthine diseases. Otolaryngology 1991, 1689-1714. WB Saunders, Philadelphia. 3rd edn. M.M. Paparella, D.A. Shumrick, J. Gluckmann, W.L. Meyerhoff (Eds.).
13. Paparella M.M. The cause (multifactorial inheritance) and pathogenesis (endololymphatic malabsorption) of Meniere's disease and its symptoms (mechanical and chemical). Acta Otolaryngol (Stockh) 1985, 99:445-451.
14. Bernstein J. Occurrence of episodic vertigo and hearing loss in families. Ann Otol Rhinol Laryngol 1965, 74:101-111.
15. Paparella M.M. Pathogenesis of Meniere's disease and Meniere's syndrome. Acta Otolaryngol Suppl 1984, 406:10-25.
16. Committee on Hearing and Equilibrium: guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Amer Acad Otolaryngol Head Neck Surg Foundation Inc. Otolaryngol Head Neck Surg 1995, 113:176-178.
17. Hallpike C.S., Cairns H. Observation on the pathology of Meniere's syndrome. J Laryngol Otol 1938, 53:625-655.
18. Yamakawa K. Uber die pathologische Veranderungbeieinem Meniere Kranken. J Otorhinolaryngol Soc Jpn 1938, 44:2310-2312.
19. Merchant S.N., Adams J.C., Nadol J.B. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops. Otol Neurotol 2005, 26(1):74-81.
20. Schuknecht H.F. Pathology of the ear 1993, Lea & Febiger, Philadelphia/Baltimore. 2nd edition.
21. Wackym P.A., Schuknecht H.F., Ward P.H., Linthicum F.H., Kerner M.M., Aframian D., et al. Blinded control study of endolymphatic duct and sac fibrosis in Meniere's disease. Meniere's disease: perspectives in the 90s 1994, 209-215. Edited by:, Kugler Publ, Amsterdam/New York. R. Filipo, M. Barbara (Eds.).
22. Nadol J.B. Positive Hennebert's sign in Ménierè's disease. Arch Otolaryngol 1977, 103:524-530.
23. Rizvi S.S. Investigations into the cause of canal paresis in Meniere's disease. Laryngoscope 1986, 96:1258-1271.
24. Ylikoski J., Collan Y., Palva T. Vestibular sensory epithelium in Meniere's disease. Arch Otolaryngol 1979, 105:486-491.
25. Mc Call A.A., Ishiyama G.P., Lopez I.A., Bhuta S., Vetter S., Ishiyama A. Histopathological and ultrastructural analysis of vestibular endorgans in Meniere's disease reveals basement membrane pathology. BMC Ear Nose Throat Disord 3 2009, 9:4.
26. Kimura R.S., Schuknecht H.F. Membranous hydrops in the inner ear of the guineapig after obliteration of the endolymphatic sac. Pract Otorhinolaryngol 1965, 27:343-354.
27. Kimura R.S. Animal models of endolymphatic hydrops. Am J Otolaryngol 1982, 3:447-451.
28. Schuknecht H.F., Northrop C., Igarashi M. Cochlear pathology after destruction of the endolymphatic sac in the cat. Acta Otolaryngol 1968, 65:479-487.
29. Cotter C.S., Singleton G.T., Corman L.C. Immune-mediated inner ear disease and parvovirus B 19. Laryngoscope 1994, 104:1235-1239.
30. Williams L.L., Lowery H.W., Shannon B.T. Evidence of persistent viral infection in Meniere's disease. Arch Otolaryngol Head Neck Surg 1987, 113:397-400.
31. Davis L.E., Johnson R.T. Experimental viral infection of the inner ear. Lab Invest 1976, 34:349-356.
32. Arnold W., Niedermeyer H.P. Herpes simplex virus antibodies in the perilymph of patients with Meniere's disease. Arch Otolaryngol HNS 1997, 123:53-66.
33. Welling B.D., Daniels R.L., Brainard J., Western L.M., Prior T.W. Detection of viral DNA in endolymphatic sac tissue from Meniere's disease patients. Am J Otol 1994, 5:639-643.
34. Altermatt H.J. Human endolymphatic sac: evidence for a role in inner ear immune defence. ORL 1990, 52:143-148.
35. Arenberg I.K., Walker D.W., Shambough E. The role of endolymphatic sac and viruses in the pathogenesis of endolymphatic hydrops: an ultrastructural analyses of endolymphatic sac biopsies. Surgery of the inner ear 1991, 31-52. Kugler, Amsterdam.
36. Meyer J.L., Strauss S.E. Comparative biology of latent varicella zoster virus and herpes simplex virus infections. J Infect Dis 1992, 166:S13-S23. suppl.
37. Sadzot-Delvaux C., Baudoux L., Defechereux P., Piette J., Rentier B. Overview of the replication cycle of varicella-zoster virus. Molecular Biology, Pathogenesis and Clinical Aspects. Contrib Microbiol Karger 1999, vol 3:21-42.
38. Sata T, Kurata T, Takimoto T. Application of immunoperoxidase method for detection of viral antigens in paraffin sections. Pathol Clin Med (Tokyo) 6: 287-294, doi:10.1007/s00405-004-0816-y.
39. Selmani Z., Marttila T., Pyykko I. Incidence of virus infection as a cause of Meniere's disease or endolymphatic hydrops assessed by electrocochleography. Eur Arch Otorhinolaryngol 2005, 262:331-334.
40. Kumagami M. Detection of viral antigen in the endolymphatic sac. Eur Arch Otorhinolaryngol 1996, 253:264-267.
41. Herriott M.N. Infectious nucleic acids, a new dimension in virology. Science 1961, 134:256-260.
42. Gacek R.R. The pathology of facial and vestibular neuronitis. Am J Otolaryngol 1999, 20:202-210.
43. Denny Brown D., Adams R.D., Fitzgerald P.J. Pathologic features of herpes zoster. A note on geniculate herpes. Arch Neurol Psychiatry 1949, 51:216-231.
44. Sawtell N.M. The probability of in vivo reactivation of herpes simplex virus increases with the number of latently infected neurons in the ganglia. J Virol 1998, 72:6888-6892.
45. Gacek R.R. Ménière' disease is a viral neuropathy. ORL 2009, 71:78-86.
46. Tyring S.K., Baker D., Snowden W. Valacyclovir for herpes simplex infection: long-term safety and sustained efficacy after 20 years experience with acyclovir. J Infect Dis 2002, 186:S40-S46. suppl.
47. Joannovic D. Zur wirkung fermentative gewonners paltungs produk teaus Geweben und Bakterien. Wein Klin Wschr 1920, 70:1410-1411.
48. Masugi M., Tomikuza Y. Uber die spezifischzy ototoxischen Veranderungen der Niere und des Leberdurch das spezifische Antiserum (Nephrotoxin und Hepatoxin). Trans Jpn Pathol 1931, 21:329-341.
49. Plotzliche Lehnhardt E. Horstorungen auf beidenseiten gleichzeitigo der nacheinan der aufgetreten. Z Laryngol Rhinol Otol 1958, 37:1.
50. Kikuchi M. On the "symphatetic otitis". Zibi Rinsyo Kyoto 1959, 52:600.
51. Beickert V. Zur Frage der Empfindungen Schwerhorigkeitunter Autoallergie. Z Laryngol Rhinol Otol 1961, 40:837-842.
52. Terayama Y., Sasaki U. Studies on experimental allergic (isoimmune) labyrinthitis in guinea pigs. Acta Otolaryngol 1964, 58:49-64.
53. Mc Cabe B. Autoimmune sensorineural hearing loss. Ann Otolaryngol 1979, 88:585-589.
54. Hughes G.B., Barna B.P., Kinney S.E., Calabrese L.H., Hamid M.A., Nalepa N. Autoimmune endolymphatic hydrops: five year review. Otolaryngol Head Neck Surg 1988, 98:221-225.
55. Hughes G.B., Kinney S.E., Barna B.P., Calabrese L.H. Autoimmune reactivity in Ménière's disease: a preliminary report. Laryngoscope 1983, 93:410-417.
56. Dornhoffer J.L., Arenberg I.K. Immune mechanisms in Meniere's syndrome. Otolaryngol Clin North Am 1997, 30:1017-1026.
57. Gloddek B., Arnold W. Clinical and experimental studies of autoimmune inner ear disease. Acta Otolaryngol Suppl 2002, 548:10-14.
58. Bernstein J.M., Shanahan T.C., Schaffer F.M. Further observations on the role of MHC genes and certain hearing disorders. Acta Otolaryngol 1996, 116:666-671.
59. Bovo R., Corba A., Martini A. Vertigo and autoimmunity. Eur Arch Otorhinolaryngol 2010, 267:1122-1125.
60. Yoo T.J., Yazawa Y., Tomoda K., Floyd R. Type II collagen-induced autoimmune endolymphatic hydrops in guinea pig. Science 1983, 113:65-67.
61. Yoo T.J. Etiopathogenesis of Ménière's disease: a hypothesis. Ann Otol Rhinol Laryngol 1984, 113:6-12.
62. Brookes G. Circulating immune complexes in Ménière's disease. Arch Otolaryngol Head Neck Surg 1986, 112:536-540.
63. Yoo T., Xianxi G., Sener O. Presence of autoantibodies in the sera of Ménière's disease. Ann Otol Rhinol Laryngol 2001, 110:425-429.
64. Wackym P.A., Friberg U., Linthicum F.H., Bagger-Sjoback D., Bui H.T., Hofman F., et al. Human endolymphatic sac: morphologic evidence of immunologic function. Ann Otol Rhinol Laryngol 1987, 96:276-281.
65. Wei N.R., Helms J., Giebel W. Immunohistochemical findings in the vestibular ganglion from a patient with Meniere's disease. Eur Arch Otorhinolaryngol 1990, 247:340-344.
66. Yoo T.J., Stuart J.M., Kang A.H., Townes A.S., Tomoda K., Dixit S. Type II collagen autoimmunity in otosclerosis and Ménière's disease. Science 1982, 217:1153-1155.
67. Yoo T.J., Shea J., Ge X., Kwon S.S., Yazawa Y., Sener O., et al. Presence of autoantibodies in the sera of Ménière's disease. Ann Otol Rhinol Laryngol 2001, 110:425-429.
68. Boulassel M.R., Tomasi J.P., Deggouj N., Gersdorff M. Identification of beta-actin as a candidate autoantigen in autoimmune inner ear disease. Clin Otolaryngol 2000, 25:535-541.
69. Ryan A.F. Immunological factors in Ménière's disease. Immunology of the ear 1987, 435-461. Raven, New York. J. Bernstein, P. Ogra (Eds.).
70. Billings P.B., Keithley E.M., Harris J.P. Evidence linking the 68kD protein in progressive sensorineural hearing loss with hsp 70. Ann Otol Rhinol Laryngol 1995, 104:181-189.
71. Tomiyama S., Harris J.P. The endolymphatic sac: its importance in inner ear immune responses. Laryngoscope 1986, 96:685-691.
72. Rauch S.D., San Martin J.P., Moscicki R.A., Bloch K.J. Serum antibodies against heat shock protein in Meniere's disease. Am J Otol 1955, 16:648-652.
73. Gottschlich S., Billings P.B., Keithley E.M., Weisman M.H., Harris J.P. Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Meniere's diseases. Laryngoscope 1995, 105:1347-1352.
74. Riente L., Bongiorni A., Nacci P., Migliorini G., Segnini G., Delle Sedie A., et al. Antibodies to inner ear antigens in Ménière's disease. Clin Exp Immunol 2004, 135:159-163.
75. Wang X., Truong T., Billings P.B., Harris J.P., Keithley E.M. Blockage of immune mediated inner ear damage by etanercept. Otol Neurotol 2003, 24:52-57.
76. Rahman M.U., Poe D.S., Choi H.K. Etanercept therapy for immune mediated cochleovestibular disorders: preliminary results in a pilot study. Otol Neurotol 2001, 22:619-624.
77. Mouadeb D.A., Ruckenstein M.J. Antiphospholipid inner ear syndrome. Laryngoscope 2005, 115:879-883.
78. Levine J., Branch W., Rauch J. The antiphospholipid syndrome. N Engl J Med 2002, 346:752-763.
79. Aziz A., Conway M.D., Robertson H.J., Espinoza L.R., Wilson W.A. Acute optic neuropathy and transverse myelopathy in patients with antiphospholipid syndrome: favorable outcome after treatment with anticoagulants and glucocorticoid. Lupus 2000, 9:307-310.
80. Suslu N., Yilmaz T., Gursel B. Utility of immunologic parameters in the evaluation of Ménière's disease. Acta Otolaryngol 2009, 129:1160-1165.
81. Raphael Y., Frisanco J.C., Roessler B.I. Adenoviral mediated gene transfer into guinea pig cochlear cells in vivo. Neurosci Lett 1996, 207:137-141.
82. Dazert Tranfection of neonatal rat cochlear cells in vitro with an adenovirus vector. Int J Dev Neurosci 1997, 15:595-600.
83. Lalwani A.K., Walsh B.J., Reilly P.G., Muzyczka N., Mhatre A.N. Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. Gene Ther 1996, 3:588-592.
84. Lalwany A.K., Han J.J., Walsh B.J., Zolotukhin S., Muzyczka N., Mhatre A.N. Green fluorescent protein as a reporter for gene transfer studies in the cochlea. Hear Res 1997, 114:139-147.
85. Staecker H., Li D., O'Malley B.W., Van de Water T.R. Gene expression in the mammalian cochlea: A study of multiple vector systems. Acta Otolaryngol 2001, 121:157-163.
86. Derby M.L., Sena-Esteves M., Breakefield X.O., Corey D.P. Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res 1999, 134:1-8.
87. Bradley W., Kesser M.D., George T., Hashisaki M.D., Holt Jeffrey R. Gene transfer in human vestibular epithelia and the prospects for inner ear gene therapy. Laryngoscope 2008, 118(5):821-831.
88. Fekete D.M., Muthukumar S., Karagogeos D. Hair cells and supporting cells share a common progenitor in the avian inner ear. J Neurosci 1998, 18:7811-7821.
89. Cotanche D.A. Structural recovery from sound and aminoglycoside damage in the avian cochlea. Audiol Neurootol 1999, 4:271-285.
90. Adler H.J., Raphael Y. New hair cells arise from supporting cell conversion in the acoustically damaged chick inner ear. Neurosci Lett 1996, 205:17-20.
91. Kesser B.W., Hashisaki G.T., Fletcher K., Eppard H., Holt J.R. An in vitro model system to study gene therapy in the human inner ear. Gene Ther 2007, 14:1121-1131.
92. Sugahara K., Shimogori H., Okuda T., Takemoto T., Yamashita H. Novel method for homogeneous gene transfer to the inner ear. Acta Otolaryngol Suppl 2004, 19-22.
93. Kanzaki S., Beyer I., Karolyi I.J., Dolan D.F., Fang Q., Probst F.J., et al. Transgene correction maintains normal cochlear structure and function in 6-month-old Myo15a mutant mice. Hear Res 2006, 214:37-40.